if the new Menactra (meningococcal conjugate vaccine) causes Guillain-Barre Syndrome

Patients and parents are asking if the new Menactra (meningococcal conjugate vaccine) causes Guillain-Barre Syndrome.

This is based on a handful of cases of Guillain-Barre...in older adolescents 2 to 5 weeks after receiving Menactra.

The rapid bilateral ascending muscle weakness and temporary paralysis is a big worry for parents.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote